With shares of Safeway (NYSE:SWY) trading around $33, is SWY an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementSafeway is a food and drug retailer in North America that operates over 1600 stores. The company�� United States retail operations are located principally in California, Hawaii, Oregon, Washington, Alaska, Colorado, Arizona, Texas, the Chicago metropolitan area, and the Mid-Atlantic region. In support of its retail operations, Safeway has a network of distribution, manufacturing, and food processing facilities. Safeway also owns and operates GroceryWorks.com, an online grocery channel doing business under the names Safeway.com and Vons.com. Safeway also has a 49 percent interest in Casa Ley, S.A. de C.V., which operates 195 food and general merchandise stores in Western Mexico.
Safeway shares are up despite the fact that the grocery store chain reported a 59 percent drop in profit for the third quarter. The reason for the Safeway optimism is that the company announced it�� leaving Chicago by the beginning of next year. The 72 Domenick�� supermarkets it owns in the city will give Safeway a $400 to $450 million cash tax benefit. Revenue grew 1.1 percent to $8.6 billion, but earnings fell short of estimates at 10 cents a share.
Best Gas Utility Companies To Buy Right Now: Savient Pharmaceuticals Inc(SVNT)
Savient Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing KRYSTEXXA, a biologic PEGylated uricase in the United States. The KRYSTEXXA is being developed as a treatment for chronic gout in patients refractory to conventional therapy. The company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. It sells its products directly to drug wholesalers. The company, formerly known as Bio-Technology General Corp. and changed its name to Savient Pharmaceuticals, Inc. in June 2003. Savient Pharmaceuticals, Inc. was founded in 1980 and is headquartered in East Brunswick, New Jersey.
Advisors' Opinion:- [By James E. Brumley]
Since 2008's implosion from the stock, the interest in Savient Pharmaceuticals Inc. (NASDAQ:SVNT) has been waning. There was a brief burst of bullishness in September of last year, which stirred the bullish pot a little. But, when SVNT started to fade in October of that year - just as quickly as it had perked up - what lingering hopes there were for the stock finally started to melt away. By the middle of this year, pretty much everyone had written Savient Pharmaceuticals off as a lost cause. Big mistake. Over the last few days, SVNT has almost wiggled its way buck into a bullish zone.
Hot Supermarket Stocks To Watch For 2014: Progenics Pharmaceuticals Inc.(PGNX)
Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases in the United States and internationally. Its primary programs focus on gastroenterology, oncology, and virology. The company offers RELISTOR (methylnaltrexone bromide) subcutaneous injection, a therapy for opioid-induced constipation. It is also conducting a Phase I clinical trial of a human monoclonal antibody-drug conjugate directed against prostate specific membrane antigen (PSMA), a protein found at high levels on the surface of prostate cancer cells, as well as in blood vessels supplying other solid tumors. In addition, the company is developing PRO 140, a viral-entry inhibitor for human immunodeficiency virus (HIV), which is in Phase II clinical testing; and multiplex PI3-Kinase inhibitors for the treatment of cancer. Progenics Pha rmaceuticals, Inc. has license agreement with Salix Pharmaceuticals, Ltd. for the development and commercialization of RELISTOR worldwide other than Japan. The company was founded in 1986 and is based in Tarrytown, New York.
Advisors' Opinion:- [By Anna Prior]
A U.S. Food and Drug Administration office has approved Salix Pharmaceuticals Ltd.'s(SLXP) appeal to gain approval for expanded usage of a constipation drug it licensed from Progenics Pharmaceuticals Inc.(PGNX), the companies said. Shares of Progenics climbed 12% to $4.75 premarket.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company Progenics Pharmaceuticals (NASDAQ: PGNX ) has received a distressing two-star ranking.
Hot Supermarket Stocks To Watch For 2014: Glu Mobile Inc.(GLUU)
Glu Mobile Inc. designs, markets, and sells mobile games worldwide. It develops original games based on its intellectual property comprising Big Time Gangsta?, Blood & Glory, Bug Village, Contract Killer, Contract Killer: Zombies, Eternity Warriors, Frontline Commando, Gun Bros, Men vs. Machines, Stardom: The A-List, Super K.O. Boxing and Toyshop Adventures. The company also develops games based on licensed intellectual property consisting of Build-a-lot, Call of Duty, Deer Hunter, DJ Hero, Guitar Hero, Family Feud, Family Guy, Lord of the Rings, Paperboy, The Price Is Right, Transformers, Who Wants to Be a Millionaire?, and World Series of Poker. It offers a portfolio of action/adventure and casual games to smartphones and tablet devices users through direct-to-consumer digital storefronts, as well as to feature phone users served by wireless carriers and other distributors. The company was formerly known as Sorrent, Inc. and changed its name to Glu Mobile Inc. in May 20 05. Glu Mobile Inc. was incorporated in 2001 and is headquartered in San Francisco, California.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
3dsystems.com With 2014 coming to a close, the market's setting itself up to post modest gains for the year. Naturally, a rising tide doesn't lift all ships. There are a few industries that have fallen out of favor this year despite the gains elsewhere. Let's take a look at three markets that have been battered in 2014. There's a lot riding on them bouncing back in the year ahead. 3-D Printing One of the hottest new industries of 2012 and 2013 was 3-D printing. 3D Systems (DDD) and Stratasys (SSYS) were two of Wall Street's biggest winners as investors got pumped about the prospects of printers that produce physical 3-D objects in a wide range of forms, colors, and textures. Reality hasn't been as kind as the romanticized vision of 3-D printing. There have been pricing and performance stumbling blocks. The machines are still too expensive and too slow. 3D Systems may have seen its stock more than triple in 2012 and more than double in 2013, but it's one of this year's most prolific laggards. Shares of 3D Systems have shed nearly two-thirds of their value. Adjusted earnings tumbled in its latest quarter, and 3D Systems warned of delays in new consumer products and a slowdown in metal printer sales. Stratasys initially held up well, but it has gone on to buckle along with 3D Systems and the other publicly traded 3-D printing specialists. It, too, had to hose down its guidance in its most recent financial report, and Stratasys stock has plunged 40 percent in 2014. Mobile Gaming We're in a mobile computing revolution, but the makers of mobile games aren't exactly feeling the love. We saw Zynga (ZNGA) implode in 2012 as gross bookings slipped at the company behind "Words With Friends" and "FarmVille"; after moving higher in 2013, it resumed its slide in 2014. Shares of Zynga have fallen 28 percent this year, and it's not alone. King Digital Entertainment (KING) went public earlier this year, hoping that it could parlay the success of its "Candy Crush Saga"
- [By Peter Graham]
The Q3 2014 earnings report for small cap social media gaming stock�Zynga Inc (NASDAQ: ZNGA), a potential peer of mobile gaming stock�Glu Mobile Inc (NASDAQ: GLUU) and interactive entertainment stock�King Digital Entertainment PLC (NYSE: KING), is scheduled for after the market closes on Thursday (November 6th). Aside from the Zynga Inc earnings report, it should be said that Glu Mobile Inc reported Q3 2014 earnings on October 29th (shares fell on profit expectations and missed revenue forecasts) while King Digital Entertainment PLC will also report Q3 2014 earnings after the market closes on Thursday. However, Zynga Inc has long struggled and has worked hard to come out from under the shadow of�Facebook Inc (NASDAQ: FB) but Wall Street and investor patience may be running out.
- [By Garrett Cook]
Technology sector was the top decliner in the market on Thursday. Top losers in the sector included QuickLogic (NASDAQ: QUIK), Glu Mobile (NASDAQ: GLUU), and L-3 Communications Holdings (NYSE: LLL).
- [By James E. Brumley]
Truth be told, with just a quick glance, Glu Mobile Inc. (NASDAQ:GLUU) doesn't look all that compelling. Oh sure - the stock's up from a low of $2.10 in late June to $2.83 right now, but that's not an unusual move for GLUU. We've seen them before, with most of them petering out rather quickly. When you take a step back and really take a good luck at the bigger picture though, you might agree that now would be a great time to quietly step into a Glu Mobile position.
Hot Supermarket Stocks To Watch For 2014: Parnassos Enterprises SA (PARN)
Parnassos Enterprises SA is a Greece-based holding company. The Company mainly operates through its subsidiary Seirios SA, which offers traveler services on the Athens - Lamia highway. Seirios SA owns a building complex with a total area of 16,720 square meters and it operates two petrol stations, a trading and repairing tire center, two road assistance buildings, two car washing stations, a laundry-lubricator station for tracks, snack bars, restaurants, and coffee shops. It also operates two more petrol stations on the Athens - Lamia highway in the Olympus Plazza block of buildings, which also operates two car washer and two track washer stations. The Company also owns, through Seirios SA, the subsidiary Alsity SA, a company which is engaged in the design, construction, development and operation of the Olympic Sailing Centre in Agios Kosmas, Greece. Advisors' Opinion:- [By John Udovich]
Biotech news this week was dominated by a number of healthcare and biotech related IPOs, including Parnell Pharmaceuticals Holdings Ltd (NASDAQ: PARN), Signal Genetics Inc (NASDAQ: SGNL), ZS Pharma Inc (NASDAQ: ZSPH), Ardelyx Inc (NASDAQ: ARDX)�and Zafgen Inc (NASDAQ: ZFGN) with Kite Pharma Inc (NASDAQ: KITE), Microlin Bio Inc (NASDAQ: MCLB) and�Syndax Pharmaceuticals Inc (NASDAQ: SNDX) presumably set to debut today (Note:�See�This Week�� Biotech IPOs: Two Losers and One Winner So Far (PARN, SGNL & ZSPH)):
No comments:
Post a Comment